| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/22/2005 | WO2005087262A1 Chicken anemia virus vaccine from cell line |
| 09/22/2005 | WO2005087261A2 Identification of self and non-self antigens implicated in autoimmune diseases |
| 09/22/2005 | WO2005087260A1 Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof |
| 09/22/2005 | WO2005087259A1 Vaccine compositions which are obtained from streptomyces |
| 09/22/2005 | WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/22/2005 | WO2005086663A2 Polypeptides for inducing a protective immune response against staphlococcus aureus |
| 09/22/2005 | WO2005086637A2 Anthrax antigens and methods of use |
| 09/22/2005 | WO2005080418A3 Multimerised hiv fusion inhibitors |
| 09/22/2005 | WO2005069855A3 Modulators of angiogenesis |
| 09/22/2005 | WO2005049072A3 Therapeutic cancer vaccine with fragments of trag-3 |
| 09/22/2005 | WO2005021734A3 Generation of hematopoietic chimerism and induction of central tolerance |
| 09/22/2005 | WO2005018580A3 Anti-cancer virus desensitization method |
| 09/22/2005 | WO2004060265A3 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 09/22/2005 | WO2004056316A8 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 09/22/2005 | WO2003062374A3 Synthetic genes for malarial proteins and methods of use |
| 09/22/2005 | WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof |
| 09/22/2005 | US20050210535 Parasite integral membrane protein for use as tool in identifying modulators and devlopment of vaccines for prevention and treatment of toxoplasmosis |
| 09/22/2005 | US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide |
| 09/22/2005 | US20050209184 Oligodeoxynucleotide and its use to induce an immune response |
| 09/22/2005 | US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor |
| 09/22/2005 | US20050209104 Dinoflagellate karlotoxins, methods of isolation and uses thereof |
| 09/22/2005 | US20050208627 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 09/22/2005 | US20050208625 Monoclonal antibodies with reduced immunogenicity |
| 09/22/2005 | US20050208607 Immunoassays for everolimus |
| 09/22/2005 | US20050208587 Fab 4E10/KGND crystal complex for use in preparing viricidal agents; rational drug design |
| 09/22/2005 | US20050208584 Using modified thanatos-associated-protein-1 (THAP1) for treatment and prevention of inflammation, arthritis and inflammatory bowel diseases |
| 09/22/2005 | US20050208583 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/22/2005 | US20050208565 29 human cancer associated proteins |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208540 Novel fibroblast growth factor and nucleic acids encoding same |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208498 Killer cell immunoglobulin-like receptor (KIR)-like protein receptor for use in diagnosis, prevention and treatment of cancer, autoimmune disease, organ transplant rejection, allergic reaction, and inflammatory disorders |
| 09/22/2005 | US20050208496 Using enhanced interleukin gene expression as diagnostic indicator of respiratory system disorders |
| 09/22/2005 | US20050208485 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes and uses thereof |
| 09/22/2005 | US20050208483 Kits for detecting anti-sirs antibodies |
| 09/22/2005 | US20050208482 Tat-based immunomodulatory compositions and methods for their discovery and use |
| 09/22/2005 | US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection |
| 09/22/2005 | US20050208480 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 09/22/2005 | US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics |
| 09/22/2005 | US20050208472 Using angiogenesis polypeptide as screening tools iin identifying modulators of for prevention and treatment of cell proliferative disorders; angiogenesis inhibitors |
| 09/22/2005 | US20050208143 made of a biodegradable polymer formed using cationic or anionic detergent the surfaces of which adsorb biologically active macromolecules, such tumor antigens; vaccine delivery |
| 09/22/2005 | US20050208123 Vaccine comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea toxin or heat labile enterotoxin; provides protection from Chlamydia induced infertility |
| 09/22/2005 | US20050208120 artificial antigen presenting cell comprising liposome comprising a fluid lipid bilayer; MHC class I and/or class II molecule associated with the bilayer complexed with an antigenic peptide; and accessory molecules associated with the bilayer; for treating autoimmune disorders, allergies, cancers, etc. |
| 09/22/2005 | US20050208103 Contacting sclera with a therapeutic or diagnostic agent so as to permit its passage into the choroidal and retinal tissues; no significant systemic absorption or tissue damage; eye disorders |
| 09/22/2005 | US20050208079 Glucan-based vaccines |
| 09/22/2005 | US20050208078 Subcutaneous, intramuscular, intradermal, mucosal, submucosal, and cutaneous inoculation with attenuated sporozoites; vaccination kits |
| 09/22/2005 | US20050208077 For the protection of fish against infection by the same and other virulent strains Streptococcus agalactiae |
| 09/22/2005 | US20050208075 Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) |
| 09/22/2005 | US20050208074 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 09/22/2005 | US20050208073 Immunogens; kits |
| 09/22/2005 | US20050208072 Preventive and therapeutic aids vaccines |
| 09/22/2005 | US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 09/22/2005 | US20050208069 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 09/22/2005 | US20050208068 Malaria immunogen and vaccine |
| 09/22/2005 | US20050208067 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 09/22/2005 | US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening |
| 09/22/2005 | US20050208065 Immunogenic compositions for induction of anti-tumor immunity |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208063 Vaccine containing a thiol protease |
| 09/22/2005 | US20050208062 Compositions and methods relating to hepatic specific genes and proteins |
| 09/22/2005 | US20050208061 Treatment of autoimmune diseases by oral administration of autoantigens |
| 09/22/2005 | US20050208060 Vaccine composition |
| 09/22/2005 | US20050208058 For treatment of cell proliferative by modulating/inhibiting centrosomal genes or polypeptides via gene silencing, antibodies, aptamers, ribozymes, and antisense nucleic acids; gene expression inhibition; tubulins |
| 09/22/2005 | US20050208057 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/22/2005 | US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening |
| 09/22/2005 | US20050208054 Screening protein kinase (Akt)/serine-threonine kinase modulators; regulating glucose transport |
| 09/22/2005 | US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera |
| 09/22/2005 | US20050208052 Screening for agonists/antagonists of interleukins; influenza virus; RNA interference; kits |
| 09/22/2005 | US20050208051 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof |
| 09/22/2005 | US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease |
| 09/22/2005 | US20050208049 Expanding CD4 + T cells; antiretroviral drug; induce active pathogen replication in cell latently infected with HIV and anti-pathogen drug |
| 09/22/2005 | US20050208048 HLA-DR specific antibodies, compositions and methods |
| 09/22/2005 | US20050208046 TWEAK receptor |
| 09/22/2005 | US20050208045 Augment signaling of ligand of receptor serine kinase in a cell, inhibit formation of complexes between developmental oncoprotein and ligand on the surface of cell |
| 09/22/2005 | US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 09/22/2005 | US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin |
| 09/22/2005 | US20050208041 Variable domain framework regions from the heavy and light chains are unaltered from the human antibody or human antibody consensus framework; additional antibody modifications to decrease antigenicity of the antibody itself; autoimmune disorder |
| 09/22/2005 | US20050208040 Polynucleotides and polypeptides encoded thereby |
| 09/22/2005 | US20050208039 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 09/22/2005 | US20050208020 Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines |
| 09/22/2005 | US20050208017 Immuno-modulating effects of chemokines in DNA vaccination |
| 09/22/2005 | US20050207975 administering monoclonal Tac-antibodies; anticarcinogenic agents; immunotherapy |
| 09/22/2005 | CA2560200A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
| 09/22/2005 | CA2559172A1 Therapeutic use of rm1 antigen |
| 09/22/2005 | CA2559144A1 Estrogen receptor alpha splice variant er-.alpha.36 |
| 09/22/2005 | CA2559124A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof |
| 09/22/2005 | CA2559069A1 Axon regeneration promoter |
| 09/22/2005 | CA2559065A1 Identification of self and non-self antigens implicated in autoimmune diseases |
| 09/22/2005 | CA2558736A1 Chicken anemia virus vaccine from cell line |
| 09/22/2005 | CA2558047A1 A canine vaccine for protection against ehrlichiosis |
| 09/22/2005 | CA2557005A1 Antineoplastic combinations of cci-779 and rituximab |
| 09/21/2005 | EP1577391A1 Neutrokine alpha |
| 09/21/2005 | EP1577387A1 Preventives/remedies for cancer |
| 09/21/2005 | EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 09/21/2005 | EP1577381A1 Tumor/B-cell hybrid cells and uses thereof |
| 09/21/2005 | EP1576967A1 Recombinant protein, carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, therapeutic uses thereof |
| 09/21/2005 | EP1576966A1 Method of preparing a vaccine and anti-tumor vaccines |
| 09/21/2005 | EP1576965A1 Combinations of growth- and hormone-regulating factors for the treatment of neoplasia |